coronary artery disease
Conditions
Interventions
DCB:drug-coated balloons
DES:drug-eluting stents
Sponsors
Yellow River Sanmenxia Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Selected criteria that comply with coronary arterial intervention therapy (according to the "Guidelines for the Treatment of Cross -Coronatte Artelis in China in 2021"), which belongs to · Protonous coronary arteries · Reference blood vessel diameter =2.0 mm and =4 mm · No severe calcification · The narrow diameter of the thrombosis and pre -expansion of the thrombosis does not exceed 50%(visual inspection)
Exclusion criteria
Exclusion criteria: 1) Age 80 years old 2) Known in intracranial diseases (lumps, aneurysm, dynamic vein malformation, hemorrhagic CVA, ischemic CVA/TIA <6 months ago, including or ischemia, (permanent nerve dysfunction) 3) Known taboos: Bidamu, sodium sodium sodium, heparin, aspirin, Praograi/or Tetkagrai 4) Pure/ventilation 5) Severe heart failure (NYHA heart function =III) or left ventricular ejection score <35% 6) Heartogenic shock 7) Bleeding risk is high (patients with a CRUSADE score standard exclude patients with high risks above the risk of risk) 8) The expected life span is less than 12 months 9) Unable to provide informed consent 10) Other researchers believe that it is not suitable for participating in the situation of this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| major adverse cardiovascular events; | — |
Secondary
| Measure | Time frame |
|---|---|
| Target lesion revascularization;Target vessel revascularization;Target vessel failure;All-cause mortality;Cardiac mortality;Myocardial infarction;In-stent thrombosis; | — |
Countries
China
Contacts
Public ContactLi Zheng
Yellow River Sanmenxia Hospital
Outcome results
None listed